Order Article Reprints

Skalska-Bugala A, Starczak M, Szukalski Ł, Gawronski M, Siomek-Gorecka A, Szpotan J, Labejszo A, Zarakowska E, Szpila A, Jachalska A, et al. Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes. Cells. 2022; 11(5):888. https://doi.org/10.3390/cells11050888

Skalska-Bugala, Aleksandra, Marta Starczak, Łukasz Szukalski, Maciej Gawronski, Agnieszka Siomek-Gorecka, Justyna Szpotan, Anna Labejszo, Ewelina Zarakowska, Anna Szpila, Anna Jachalska, and et al. 2022. "Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes" Cells 11, no. 5: 888. https://doi.org/10.3390/cells11050888

Skalska-Bugala, A., Starczak, M., Szukalski, Ł., Gawronski, M., Siomek-Gorecka, A., Szpotan, J., Labejszo, A., Zarakowska, E., Szpila, A., Jachalska, A., Szukalska, A., Kruszewski, M., Sadowska, A., Wasilow, A., Baginska, P., Czyz, J., Olinski, R., Rozalski, R., & Gackowski, D. (2022). Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes. Cells, 11(5), 888. https://doi.org/10.3390/cells11050888